These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8200889)

  • 21. Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur.
    Chen X; Schmidt AH; Tsukayama DT; Bourgeault CA; Lew WD
    J Bone Joint Surg Am; 2006 Jul; 88(7):1510-23. PubMed ID: 16818977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone defect healing with an osteogenic protein-1 device combined with carboxymethylcellulose.
    Cook SD; Salkeld SL; Patron LP
    J Biomed Mater Res B Appl Biomater; 2005 Oct; 75(1):137-45. PubMed ID: 16035032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys.
    Hanisch O; Sorensen RG; Kinoshita A; Spiekermann H; Wozney JM; Wikesjö UM
    J Periodontol; 2003 May; 74(5):648-57. PubMed ID: 12816297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats.
    Lieberman JR; Daluiski A; Stevenson S; Wu L; McAllister P; Lee YP; Kabo JM; Finerman GA; Berk AJ; Witte ON
    J Bone Joint Surg Am; 1999 Jul; 81(7):905-17. PubMed ID: 10428121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
    Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
    Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2).
    Sellers RS; Zhang R; Glasson SS; Kim HD; Peluso D; D'Augusta DA; Beckwith K; Morris EA
    J Bone Joint Surg Am; 2000 Feb; 82(2):151-60. PubMed ID: 10682724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants.
    Cochran DL; Schenk R; Buser D; Wozney JM; Jones AA
    J Periodontol; 1999 Feb; 70(2):139-50. PubMed ID: 10102551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New-bone formation by osteogenic protein-1 and autogenic bone marrow in a critical tibial defect model in sheep].
    Regauer M; Jürgens I; Kotsianos D; Stützle H; Mutschler W; Schieker M
    Zentralbl Chir; 2005 Aug; 130(4):338-45. PubMed ID: 16103959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs.
    Itoh T; Mochizuki M; Nishimura R; Matsunaga S; Kadosawa T; Kokubo S; Yokota S; Sasaki N
    J Vet Med Sci; 1998 Apr; 60(4):451-8. PubMed ID: 9592717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model.
    Kokubo S; Fujimoto R; Yokota S; Fukushima S; Nozaki K; Takahashi K; Miyata K
    Biomaterials; 2003 Apr; 24(9):1643-51. PubMed ID: 12559824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.
    Friedlaender GE; Perry CR; Cole JD; Cook SD; Cierny G; Muschler GF; Zych GA; Calhoun JH; LaForte AJ; Yin S
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S151-8. PubMed ID: 11314793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of two biomaterial carriers for osteogenic protein-1 (BMP-7) in an ovine critical defect model.
    Pluhar GE; Turner AS; Pierce AR; Toth CA; Wheeler DL
    J Bone Joint Surg Br; 2006 Jul; 88(7):960-6. PubMed ID: 16799005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of recombinant human osteogenic protein-1 (rhOP-1) placed with dental implants in fresh extraction sites.
    Cook SD; Salkeld SL; Rueger DC
    J Oral Implantol; 1995; 21(4):281-9. PubMed ID: 8699520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats.
    Yasko AW; Lane JM; Fellinger EJ; Rosen V; Wozney JM; Wang EA
    J Bone Joint Surg Am; 1992 Jun; 74(5):659-70. PubMed ID: 1378056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model.
    Suga K; Saitoh M; Kokubo S; Nozaki K; Fukushima S; Yasuda S; Sasamata M; Miyata K
    J Interferon Cytokine Res; 2004 Jun; 24(6):343-9. PubMed ID: 15212708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological and radiographic comparison of allograft substitutes using a continuous delivery model in segmental defects.
    Marks T; Wingerter S; Franklin L; Woodall J; Tucci M; Russell G; Patel R; Benghuzzi H
    Biomed Sci Instrum; 2007; 43():194-9. PubMed ID: 17487080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs.
    Cook SD; Patron LP; Salkeld SL; Rueger DC
    J Bone Joint Surg Am; 2003; 85-A Suppl 3():116-23. PubMed ID: 12925618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone.
    Johnson EE; Urist MR; Finerman GA
    Clin Orthop Relat Res; 1992 Apr; (277):229-37. PubMed ID: 1555346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a compression resistant matrix for recombinant human bone morphogenetic protein-2.
    Lu SX; Fiorini T; Lee J; Prasad HS; Buxton AN; Bisch FC; Dixon DR; Susin C; Wikesjö UM
    J Clin Periodontol; 2013 Jul; 40(7):688-97. PubMed ID: 23627347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
    Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
    Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.